Every Form 4 that NICE Ltd (NICE) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow NICE and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NICE filings page.
NICE Ltd. (NICE) reported that executive vice president of human resources Neder Shiri received a grant of 7,500 stock options on September 8, 2026. The options have an exercise price of 0.3349 per underlying ordinary share and expire on September 8, 2032.
Each option is exercisable for one ordinary share, for a total of 7,500 underlying ordinary shares. According to the vesting terms, 50% of the options vest on August 25, 2027, and the remaining 50% vest in equal quarterly installments through August 25, 2029. No Rule 10b5-1 trading plan is reported for this grant.
NICE Ltd. director Zehava Simon exercised stock options covering 554 Ordinary Shares on 2026-08-13 at an exercise price of $0.3076 per share. The option, which was fully vested and exercisable, was fully converted, leaving 0 options from this grant and resulting in 4,689 Ordinary Shares held directly after the transaction.
NICE Ltd. executive Udi Yehuda Dayan, VP Corporate Finance, reported an option exercise and share sale. On 2026-08-07 he exercised 500 stock options for Ordinary Shares at an exercise price of $0.306 per share, from a fully vested and currently exercisable option grant. The exercise yielded 500 Ordinary Shares, which were then sold the same day at $100.00 per share. Following the transaction, 250 options on Ordinary Shares from this grant remained outstanding, expiring on 2028-03-14.
NICE Ltd. reported that Chief Executive Officer Russell Scott Edward received equity compensation and had a small tax-related share disposition. On June 9, 2026, he was granted 70,000 Ordinary Shares in the form of restricted stock units that vest in four equal annual installments beginning on February 18, 2027. He was also granted 28,000 Performance Share Units, each tied to one Ordinary Share and eligible to vest over a three-year performance period ending February 18, 2029, based on specified stock price performance thresholds. On July 1, 2026, 2,051 Ordinary Shares were disposed of at $90.85 per share to cover tax obligations, a non-market tax-withholding transaction. Following these transactions, he directly holds 131,887 Ordinary Shares.
NICE Ltd. director Yocheved Dvir exercised stock options to acquire 3,036 Ordinary Shares on June 15, 2026. The Form 4 shows five separate option exercises, with exercise prices ranging from $0.2657 to $0.3076 per share. Following these transactions, Dvir directly holds 3,431 Ordinary Shares. The filing reports only exercises of fully vested options and no share sales.
NICE Ltd. director Ben-Shaoul Rimon exercised stock options to acquire 3,036 Ordinary Shares on June 3, 2026. The options were fully vested and exercisable, with exercise prices between 0.2657 and 0.3076 per share. Following these transactions, he holds 4,031 Ordinary Shares directly.
NICE Ltd. director Dan Michael Falk exercised stock options to acquire 696 Ordinary Shares. The options were fully vested and exercisable, and following the transaction he directly holds 696 Ordinary Shares, with the exercised option position reduced to zero.
NICE Ltd. director Simon Zehava exercised stock options to acquire 696 Ordinary Shares on May 13, 2026. The options carried an exercise price of 0.2929 per share and were fully vested and exercisable. Following the transaction, Zehava directly holds 4,135 Ordinary Shares of NICE Ltd.
NICE Ltd. Chief Executive Officer Russell Scott Edward reported a tax-withholding disposition of 2,051 Ordinary Shares at $110.26 per share. This was not an open-market sale but shares withheld to satisfy tax obligations. After this transaction, he directly holds 63,938 Ordinary Shares. This holding includes 30,250 restricted stock units and 15,125 performance stock units, each representing a contingent right to receive one Ordinary Share as they vest under their award terms.
NICE Ltd. reported that VP, General Counsel & Corporate Secretary Levy Meir Alon received a grant of stock options. The award covers 5,000 options for Ordinary Shares with an exercise price of $0.3211 per share and an expiration date of April 1, 2032.
The options vest in substantially equal installments on April 1, 2027, April 1, 2028, April 1, 2029, and April 1, 2030. Following this grant, Alon holds a total of 5,000 options directly.
NICE Ltd. reported that VP of Corporate Finance Dayan Udi Yehuda received a grant of 5,000 stock options linked to 5,000 Ordinary Shares. The options have an exercise price of 0.3211 per share and expire on April 1, 2032. According to the disclosure, the stock option will vest in substantially equal installments on April 1, 2027, April 1, 2028, April 1, 2029, and April 1, 2030. This is a compensation-related award, not an open-market purchase or sale, and after the grant he holds 5,000 options directly.